Paracelsus Elena Klinik Kassel   Report issue

Academic/Hospital Phase 2
Founded: Kassel Germany

Organization Overview

First Clinical Trial
2011
NCT01766258
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Paracelsus Elena Klinik | Paracelsus-Elena-Klinik Kassel | Paracelsus-Elena-Klinik, Klinikstr. 16, 34128 Kassel, Germany

Active Ingredients

Drugs in Phase 2 Trials (3)

carbidopa (sinemet) (1 trial)

entacapone (comtan) (1 trial)

levodopa (larodopa) (1 trial)

Drugs in Other Trials (2)

ioflupane i-123 (1 trial)

rasagiline (azilect) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Parkinson Disease (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 5